Elexacaftor/tezacaftor/ivacaftor treatment is associated with epigenetic age deceleration in cystic fibrosis
Josh P Dyce, Ana I. Hernández Cordero, Michael Steffen Kobor, Julie MacIsaac, Amrit Singh, Janice M. Leung, Bradley S. Quon
This study shows that ETI treatment in CF patients reduces epigenetic age acceleration, linked to inflammation and disease activity.
bioRxiv · Sep 18, 2026 · PreprintGenetics